相关实验视频

Updated: Jul 9, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

GTAMP-DTA:图形变压器与注意力机制相结合,用于药物标结合亲缘关系预测

Chuangchuang Tian¹, Luping Wang¹, Zhiming Cui¹

¹College of Electronic and Information Engineering, Suzhou University of Science and Technology, Suzhou 215009, China.

Computational biology and chemistry

|December 1, 2023

概括

通过整合注意力机制和融合变压器,GTAMP-DTA增强了药物向亲和力预测 (DTA). 这种新的方法提高了预测准确度,在关键数据集上表现优于现有的方法.

科学领域:

计算化学是一种计算化学.
生物信息学是一种生物信息学.
机器学习在药物发现中的作用

背景情况:

药物向亲和力预测 (DTA) 对于有效的药物开发至关重要.
现有的DTA机器学习方法面临缺少数据和有限的交互范围的挑战.
当前的模型往往忽视了多种药物与蛋白质相互作用的复杂相互作用.

研究的目的:

开发一个先进的机器学习模型,GTAMP-DTA,用于更准确的药物向亲和力预测.
为了解决数据的局限性,并提高对药物蛋白相互作用的理解.
提高药物发现管道中预测的可靠性.

主要方法:

GTAMP-DTA利用注意力机制将矢量分配给原子和氨基酸,捕获相互作用细节.
一个融合变压器从序列中学习蛋白质特征,并将它们与SMILES衍生的分子特征合并.
自主监督的预先训练的嵌入被用来缓解与标签数据不足相关的问题.

主要成果:

与最先进的方法相比,GTAMP-DTA在戴维斯和KIBA基准数据集上表现出卓越的性能.
评估包括各种聚合层 (最大,平均,总和) 和注意力机制变化,证实了模型的稳定性.
该模型有效地捕获复杂的药物蛋白相互作用信息,从而带来显著的性能提升.

结论:

GTAMP-DTA在药物向亲和力预测的准确性和可靠性方面取得了重大进展.
该模型的架构有效地整合了各种数据源和交互模式.
这种方法有望加速药物发现和开发过程.

关键词:

注意力机制注意力机制深度学习是一种深度学习.药物向的亲和力药物向的亲和力图形转换器的图形转换器预先接受过培训的人.

更多相关视频

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

A Protocol for Computer-Based Protein Structure and Function Prediction

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

相关概念视频

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Conserved Binding Sites

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...

The Two-State Receptor Model

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Drug-Receptor Interactions

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....